influential [idcn]
calcium antagonist [phsu]
alpha blockers [phsu]
Insulin Sensitivity [patf]
Glucose tolerance [phsf]
hypertensive [fndg]
Patients [podg]
treatment [ftcn]
Thiazide Diuretics [orch, phsu]
Impaired glucose tolerance [dsyn]
Biochemical [ftcn]
Diabetes [dsyn]
Insulin Resistance [patf]
Effect [qlco]
Diuretics [phsu]
Glucose tolerance [phsf]
Dose [qnco]
Spironolactone [phsu, strd]
Not [ftcn]
Glucose tolerance [phsf]
High [qlco]
Dosage [qnco]
Diuretics [phsu]
Comparison [acty]
Doses [qnco]
Not Equal [qlco]
Diuretic [phsu]
Induced [ftcn]
glucose metabolism [moft]
Not [ftcn]
Altered [ftcn]
Potassium [elii]
Homeostasis [biof]
Impaired glucose tolerance [dsyn]
Occur [acty]
Low dose [qnco]
thiazide [orch, phsu]
Combined [qlco]
Potassium [elii]
Agent [chvf]
effects [qlco]
Diuretics [phsu]
glucose homeostasis [phsf]
Large [qnco]
Part [spco]
Probably [idcn]
Reversible [ftcn]
Disturbance [qlco]
glucose metabolism [moft]
Detected [fndg]
Only [qnco]
Detailed [qlco]
biochemical testing [lbpr]
Clinical [qlco]
Relevance [qlco]
Uncertain [idcn]
Established [qlco]
Diabetes [dsyn]
Diuretics [phsu]
Rapid [qlco]
Adverse Effect [fndg]
Metabolic Control [moft]
Subject [grup]
Diuretics [phsu]
Rarely [qlco]
Trigger [clna]
Serious [qlco]
Hyperosmolarity [fndg]
Non [ftcn]
Ketoses [carb]
diabetic [fndg]
Syndrome [dsyn]
Not [ftcn]
Known [qlco]
Metabolic [ftcn]
Clinical [qlco]
Diabetes [dsyn]
???lead [elii, hops]
Microvascular [ftcn]
Complications [patf]
Long-term [tmco]
Evidence [ftcn]
Large [qnco]
Outcome [ftcn]
Trial [resa]
Suggest [idcn]
Biochemical [ftcn]
Diabetes [dsyn]
Glucose Intolerance [dsyn]
Insulin Resistance [patf]
Not [ftcn]
Increase [ftcn]
Risk [qlco]
coronary heart disease [dsyn]
treated [topp]
hypertensive [fndg]
Patients [podg]
Diuretics [phsu]
Patients [podg]
Diabetes [dsyn]
Essential [qlco]
Low dose [qnco]
thiazide [orch, phsu]
Excellent [qlco]
choice [inbe]
First-Line Therapy [topp]
Antihypertensive [phsu]
Dihydropyridine [orch, phsu]
calcium antagonist [phsu]
Diltiazem [orch, phsu]
Verapamil [orch, phsu]
APPEAR [qlco]
To [qlco]
effects [qlco]
glucose homeostasis [phsf]
Very [qlco]
Limited [ftcn]
Evidence [ftcn]
Alpha [inpr]
antagonists [chvf]
Increase [ftcn]
Insulin Sensitivity [patf]
Metabolic [ftcn]
Drug [phsu]
Class [inpr]
Established [qlco]
Only [qnco]
Outcome [ftcn]
Trial [resa]
coronary [bpoc]
Events [evnt]
End Point [qlco]
